Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Chronic Neutrophilic Leukemia: early-phase trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Chronic Neutrophilic Leukemia: 3 US clinical trials tracked, none currently recruiting.

Chronic Neutrophilic Leukemia is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Oncology Group, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-neutrophilic-leukemia

OPEN 0 | RECR 0% | LATE 1 | EARLY 2 | RANK #5209 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Neutrophilic Leu (th…0%
Open-enrollment share among volume-matched conditions near Chronic Neutrophilic Leukemia

Chronic Neutrophilic Leukemia has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Neutrophilic Leukemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Neutrophilic Leukemia is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Chronic Neutrophilic Leukemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

supersaturated calcium phosphate rinse Drug
1 trials
Pevonedistat Drug
1 trials
Fedratinib Pill Drug
1 trials
quality-of-life assessment Procedure
1 trials
questionnaire administration Other
1 trials
placebo Other
1 trials
Azacitidine Drug
1 trials
Venetoclax Drug
1 trials

US sites by state

Facility locations filed on Chronic Neutrophilic Leukemia trials. A trial with sites in several states counts in each.

Michigan 2 trials
Florida 2 trials
Texas 1 trials
Ohio 1 trials
Mississippi 1 trials
Minnesota 1 trials
Massachusetts 1 trials
Louisiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Neutrophilic Leukemia page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Chronic Neutrophilic Leukemia trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Children's Oncology Group sponsors the most Chronic Neutrophilic Leukemia trials on record, review their full trial history before evaluating a specific study. See Children's Oncology Group's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Neutrophilic Leukemia condition card totals 3 registered trials; most-linked intervention supersaturated calcium phosphate rinse; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.